Government Refund vs. Claim Sale: Pros, Cons, and Break-Even Analysis

You have a validated IEEPA tariff refund claim. The government owes you money. Now you have a choice: wait 18–36 months for CBP to process your full refund (plus statutory interest), or sell your claim to a qualified buyer and receive 70–85% of the value within 14–21 business days.

This is a financial decision, not a legal one. The legal question — whether IEEPA tariffs were constitutional — is settled. The Supreme Court ruled 6-3 that they were not. What remains is a capital allocation question: what is your money worth to you today versus in two years?

Most articles about this decision oversimplify it. They either push waiting (“don’t leave money on the table”) or push selling (“a bird in the hand”). The right answer depends on your company’s specific financial situation, and we’re going to give you the framework to figure it out.

The Two Paths: Side by Side

Before we get into the math, let’s lay out what each option actually looks like.

Government refund through CAPE

• Amount received: 100% of validated IEEPA duties + statutory interest
• Timeline: 2–36+ months depending on queue position and data readiness
• Risk: Low (refund is legally certain), but timing is uncertain
• Effort: Data preparation, filing, monitoring, potential follow-up with CBP
• Cost: Customs broker fees for filing, internal staff time

Claim sale (immediate capital)

• Amount received: 70–85% of validated claim value
• Timeline: 14–21 business days from agreement execution
• Risk: None — non-recourse sale, no clawback regardless of outcome
• Effort: Share data under NDA, review and sign assignment agreement
• Cost: The discount (15–30% of claim value)

The core tradeoff is clear: full amount later versus discounted amount now. But the devil is in the details, and the details revolve around one number: your cost of capital.

The Net Present Value (NPV) Framework

The right way to compare these options is net present value — what each option is worth in today’s dollars, accounting for the time value of money.

Government refund NPV calculation

The government refund includes statutory interest, which is set quarterly by the IRS. Recent rates have averaged approximately 4–5% annually. So a $1 million claim processed in 24 months would pay out approximately $1,080,000–$1,100,000 (principal plus interest).

But that $1.1M in 24 months isn’t worth $1.1M today. To calculate what it’s worth now, you discount it by your company’s weighted average cost of capital (WACC).

Formula: NPV = Future Value / (1 + WACC)^years

Claim sale NPV calculation

The claim sale is simple: you receive the discounted amount today. Its NPV equals the cash received, because there’s no waiting.

The comparison

Now compare the two:

At a 12% WACC with a 24-month timeline, the government path has a slightly higher NPV than even an 85% claim sale. But change any of those variables — higher WACC, longer timeline, lower payout discount — and the math shifts.

The Break-Even Analysis

The break-even point is the timeline at which waiting for the government refund produces the same NPV as selling today. Beyond that point, waiting actually costs you money relative to selling.

Break-even formula

Break-even occurs when: Claim Sale Amount = (Claim + Statutory Interest) / (1 + WACC)^years

Here are the break-even timelines for different scenarios:

How to read this: If your WACC is 12% and you can sell at 80% of claim value, the break-even point is 1.9 years. If you expect the government refund to take longer than 1.9 years, selling is the better financial decision.

For many importers, this is the “aha” moment. The government path only wins if it’s faster than the break-even timeline. And with CAPE queue projections stretching to 18–36 months for many filers, the math often favors selling — especially at higher WACC levels.

Get your free Impact Assessment →

Decision Matrix: Which Path Fits Your Company?

The NPV analysis provides the mathematical framework, but real decisions involve factors beyond pure math. Here’s how different company profiles typically map to each path:

Government path is better when:

• Low WACC (under 8%). Your cost of capital is low enough that waiting doesn’t significantly erode value.
• No near-term cash needs. You don’t need the refund capital for operations, expansion, or debt service.
• Early CAPE queue position. You expect to be in the first processing wave (2–4 months), not the back of the line.
• Small claims (under $250K). Claim buyers typically have minimums, and the transaction costs of a sale may not justify the discount.
• Patient capital structure. Your investors or owners are comfortable with a multi-year recovery timeline.

Claim sale is better when:

• High WACC (above 10%). The opportunity cost of waiting exceeds the discount you’d give to a buyer.
• Immediate cash needs. You need capital for inventory, equipment, hiring, or debt reduction within 90 days.
• Seasonal business. Missing a buying season because your capital is locked in a government queue is costly.
• Debt covenants. The refund capital could cure a covenant violation or improve your borrowing terms.
• Late CAPE queue position. You expect to be in a later processing wave (12–24+ months).
• Risk aversion. You prefer certainty of amount and timing over theoretical maximum recovery.

Hybrid approach is better when:

• Large claims ($1M+). You can sell a portion for immediate cash needs and file the rest through CAPE.
• Mixed urgency. Some capital needs are immediate; others can wait.
• Diversified entry portfolio. Some entries are PSC-eligible (fast government path) while others require CAPE (slow).
• Moderate WACC (8–12%). The break-even analysis is close enough that splitting the claim reduces overall risk.

Worked Examples

Let’s walk through three realistic scenarios to see how the decision plays out in practice.

Example 1: Mid-Size Importer — $2M Claim

Profile: Consumer electronics importer, $50M annual revenue, 12% WACC, moderate cash reserves, no immediate debt pressure.

• Government path NPV (24-month estimate): $1,737,628
• Claim sale at 80%: $1,600,000 today
• Break-even: 1.9 years

Decision: The government path has a higher NPV at the expected 24-month timeline, but only by $137,628. If there’s any risk the timeline extends beyond 24 months (which is likely for importers not in the first CAPE wave), the sale becomes the better bet. Recommendation: File through CAPE for the fastest government path, but seriously consider selling 30–50% of the claim for immediate capital to hedge against timeline risk.

Example 2: Large Importer — $10M Claim

Profile: Industrial equipment manufacturer, $200M annual revenue, 10% WACC, currently carrying $15M in revolving credit debt at 8.5%.

• Government path NPV (24-month estimate): $9,008,264
• Claim sale at 82%: $8,200,000 today
• Break-even: 2.0 years

Decision: If the $8.2M immediate capital is used to pay down revolving debt, the company saves approximately $697,000 in annual interest expense. Over 24 months, that’s $1.39M in savings — which nearly closes the gap with the government path NPV. Recommendation: Sell the claim and deploy the capital to reduce debt. The net financial position is nearly identical, but with zero timing risk.

Example 3: Small Importer — $500K Claim

Profile: Specialty food importer, $8M annual revenue, 15% WACC, seasonal business with a critical buying season in Q3.

• Government path NPV (18-month estimate): $408,163
• Claim sale at 75%: $375,000 today
• Break-even: 2.1 years

Decision: The $375,000 in immediate capital would fund the entire Q3 buying inventory. Missing the buying season would cost far more in lost revenue than the $125K discount. Recommendation: Sell the claim. The operational value of having capital for the buying season far exceeds the theoretical savings of waiting for the full government refund.

Factors Most People Miss

Statutory interest isn’t guaranteed at current rates

CBP pays interest under 19 U.S.C. Section 1505(c), but the rate is set quarterly by the IRS and fluctuates. The 4–5% rate used in our analysis could drop in future quarters, reducing the government path’s advantage.

Timeline estimates are optimistic for most importers

The 2–4 month “first wave” CAPE timeline only applies to importers who have validated data ready on launch day. For everyone else, realistic timelines are 12–36 months. If your data isn’t ready today, you’re probably not in the first wave. The cost of waiting breaks down why even small delays compound significantly.

Tax implications differ

A government refund may be treated differently for tax purposes than a claim sale, depending on how you accounted for the original tariff payments. Consult your tax advisor, but generally: if you expensed the tariffs when paid, the refund is taxable income when received. A claim sale is taxable in the year of sale. The timing difference in tax obligations can affect your after-tax comparison.

Partial sales are possible

You don’t have to sell your entire claim. Many importers sell 30–60% of their claim for immediate capital and file the remainder through CAPE. This hedges your bets: you get some cash now and preserve the upside on the rest. The immediate capital guide explains how partial sales work.

Your CAPE queue position matters more than you think

The difference between being in the first CAPE processing wave and the third could be 12–18 months. That timeline shift dramatically changes the NPV comparison. If you haven’t started preparing your CAPE data yet, factor a later queue position into your calculations. The CAPE queue filing position guide helps you estimate where you’ll land.

The Emotional Factor: Why Rational Math Isn’t Always Enough

The NPV analysis says one thing; your gut says another. That’s normal. Selling a claim at 80% feels like giving away money, even when the math says it’s the right call. Let’s address the emotional factors that often override rational analysis.

”I don’t want to leave money on the table”

This is the most common objection to claim assignment. And it’s understandable — watching someone else collect 20% of “your” money feels wrong. But consider the reframe: you’re not leaving money on the table. You’re paying for certainty, speed, and the ability to deploy capital immediately. That has real value. Insurance is a cost, but nobody calls it “leaving money on the table."

"The government owes me this money — I should get all of it”

They do owe you. And you will get all of it — eventually — if you wait for the government path. The question is whether “all of it in 24 months” is better than “most of it in 21 days.” For some companies, the answer is clearly yes, wait. For others, the math and the operational reality clearly favor selling. Neither answer is wrong.

”What if CAPE processes faster than expected?”

It could. And if it does, importers who waited will feel vindicated. But betting your capital allocation strategy on government processing being faster than projected is a bet most CFOs wouldn’t take in any other context. The downside risk (CAPE takes longer than expected) is much more likely than the upside scenario (CAPE processes in record time).

”I don’t trust claim buyers”

Valid concern. The claim acquisition space includes both reputable and less-than-reputable players. Do your due diligence. Ask for references. Review the agreement with counsel. Make sure the purchase is truly non-recourse. Our guide to evaluating recovery firms covers what to look for. But don’t let distrust of one firm prevent you from exploring a path that might be financially optimal.

Making Your Decision

Here’s a simple decision tree:

1. Calculate your WACC. If you don’t know it, use your blended cost of debt as a proxy.
2. Estimate your realistic CAPE timeline. Be honest — are you in the first wave? If not, assume 18–30 months.
3. Find your break-even point in the table above.
4. If your estimated timeline exceeds break-even: selling is likely the better financial decision.
5. If your estimated timeline is shorter than break-even: the government path wins on NPV.
6. If it’s close: consider a hybrid approach — sell a portion, file the rest.

The four recovery paths guide provides additional context on each option, and our Impact Assessment includes a customized NPV analysis based on your actual claim data, WACC, and estimated queue position.

Frequently Overlooked: The Operational Value of Cash

NPV analysis captures the financial math, but it often misses the operational value of having cash in hand. Consider these scenarios where the cash itself — not just its financial return — creates value:

Working capital for growth

A company with a validated $3 million IEEPA refund claim and $3 million in pending purchase orders for a new product launch faces a real choice. Waiting 18 months for the full government refund means either financing the launch with debt (adding interest cost) or delaying the launch (losing first-mover advantage). Selling the claim at 80% delivers $2.4 million in 21 days — enough to fund the launch immediately.

The “lost” $600K from the discount is actually the cost of accessing growth capital. Compare that to the cost of a bridge loan, a delayed launch, or a missed market window, and the discount often looks reasonable.

Debt service and covenant compliance

Companies carrying tariff-related debt — loans taken to cover the increased duty costs during the IEEPA period — may face covenant pressure. An immediate capital infusion from claim assignment can cure covenant violations, reduce interest expense, and improve lender relationships. The financial benefit of staying in covenant compliance often exceeds the claim sale discount.

Employee retention and operational stability

Companies that cut staff, reduced hours, or deferred raises during the IEEPA period face retention risk. A rapid capital recovery allows investment in people — retention bonuses, deferred raises, rehiring — that preserves organizational capacity. The cost of replacing trained employees typically runs 50–200% of annual salary, making the “soft” value of cash in hand very real.

Don’t let this decision default to “do nothing.” Inaction is the most expensive option of all — you’re earning below-market returns on capital that should be working for your business. Whether you file through CAPE or sell your claim, the first step is the same: know your numbers.